• $133.2M
    Market Cap
  • -62.04%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
750.0M
N/A
N/A
N/A
Cost of Revenue
3.7M
+138.02%
1.6M
-6.28%
1.7M
+44.00%
1.1M
+279.54%
Gross Profit
6.3M
+113.07%
3.0M
+10.29%
2.7M
+39.19%
1.9M
+252.28%
Sales and Marketing Expense
48.3M
+69.57%
28.5M
+31.24%
21.7M
+15.02%
18.9M
N/A
Research and Development Expense
-42.8M
+24.76%
-34.3M
+28.79%
-26.7M
+68.03%
-15.9M
+133.08%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
48.3M
+69.57%
28.5M
+31.24%
21.7M
+15.02%
18.9M
-67.31%
Operating Profit
-83.5M
+41.96%
-58.8M
+30.39%
-45.1M
+38.78%
-32.5M
+23.84%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
-151,000
0.00%
-151,000
-306.85%
73,000
+148.67%
Income before Taxes
-90.1M
+52.08%
-59.2M
+37.08%
-43.2M
+38.39%
-31.2M
-71.74%
Income Taxes
1.0M
-64.02%
2.8M
+294.05%
-1.4M
-223.61%
1.2M
-80.39%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-90.1M
+52.08%
-59.2M
+37.08%
-43.2M
+38.39%
-31.2M
-71.74%
Net Income from Continuing Operations Applicable to Common
-90.1M
+52.08%
-59.2M
+37.08%
-43.2M
+38.39%
-31.2M
-71.74%
Basic EPS and Net Income
-2.36
+30.68%
-1.81
+17.09%
-1.54
+27.79%
-1.21
-47.93%
Diluted EPS and Net Income
-2.36
+30.68%
-1.81
+17.09%
-1.54
+27.79%
-1.21
-47.93%
Basic Weighted Average Shares
38.1M
+16.38%
32.7M
+17.07%
28.0M
+8.32%
25.8M
+8.52%
Diluted Weighted Average Shares
38.1M
+16.38%
32.7M
+17.07%
28.0M
+8.32%
25.8M
+8.52%
Balance Sheet
Cash and Cash Equivalents
30.0M
-12.24%
34.2M
+58.20%
21.6M
+20.81%
17.9M
+205.52%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
30.0M
-12.24%
34.2M
+58.20%
21.6M
+20.81%
17.9M
+205.52%
Total Current Assets
61.2M
-37.59%
98.1M
+43.50%
68.4M
-31.83%
100.3M
-28.42%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
4.1M
-14.75%
4.8M
+13.49%
4.2M
+70.24%
2.5M
-75.64%
Total Long-Term Assets
57.3M
-5.08%
60.3M
+8.09%
55.8M
+21.82%
45.8M
+48.88%
Total Assets
118.5M
-25.21%
158.4M
+27.59%
124.2M
-15.00%
146.1M
-14.49%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
49.0M
+127.40%
21.5M
+49.06%
14.4M
-3.15%
14.9M
+28.87%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
20.4M
-13.71%
23.6M
+102.04%
11.7M
+7.92%
10.8M
+1.86%
Total Liabilities
69.3M
+53.57%
45.2M
+72.76%
26.1M
+1.51%
25.7M
+15.94%
Retained Earnings
-306.0M
+40.55%
-217.7M
+35.38%
-160.8M
+36.05%
-118.2M
-32.21%
Total Stockholders Equity
6.5M
+1.17%
6.4M
-96.72%
196.0M
-18.53%
240.6M
-19.04%
Total Shares Outstanding
43.0M
+14.96%
37.4M
+30.53%
28.7M
+10.94%
25.8M
+0.29%
Cash Flow
Cash from Operating Activities
-69.0M
+40.13%
-49.2M
+9.93%
-44.8M
+55.72%
-28.8M
+384.76%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
28.3M
+273.55%
-16.3M
-151.00%
32.0M
+135.59%
-89.9M
+1,452.13%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
38.1M
-50.79%
77.4M
+359.36%
16.9M
+1,814.95%
-983,000
-240.43%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
99.78%
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
-6.01%
N/A
N/A
N/A
Return on Assets
-65.07%
+55.20%
-41.93%
+31.10%
-31.98%
+62.29%
-19.71%
N/A
Return on Equity
-1,392.89%
+2,280.51%
-58.51%
+195.66%
-19.79%
+70.46%
-11.61%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
1.25
-72.56%
4.56
-3.73%
4.73
-29.61%
6.72
N/A
Cash Ratio
0.61
-61.41%
1.59
+6.13%
1.50
+24.74%
1.20
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow